Blaise_logo_splashBlaise_logo_splashBlaise_logo_splashBlaise_logo_splash
  • Home
  • About
    • Overview
    • Market Expertise
      • Biotechnology
      • Pharmaceuticals
      • Medical Devices
      • Contract Services
    • Letter From the Chairman
  • Search Services
    • Search Services
    • CEO
    • Board
    • Executive
    • Sample Placements
  • Search Process
    • Search Process
    • Step-By-Step
    • Diversity Initiatives
    • Succession Planning
  • Strategic Services
  • Client Login
  • Candidate Login
  • News & Events
    • News
    • Events
  • Contact
✕
Latest Caribou data add to ‘off the shelf’ cell therapy’s durability questions
June 10, 2022
Game on for Akili as it hires commercial lead for its digital-first launch of its new game therapy for ADHD
June 10, 2022
Latest Caribou data add to ‘off the shelf’ cell therapy’s durability questions
June 10, 2022
Game on for Akili as it hires commercial lead for its digital-first launch of its new game therapy for ADHD
June 10, 2022
0
Published by at June 10, 2022
Categories
Tags

Bavarian Nordic announced the U.S. Biomedical Advanced Research and Development Authority has ordered an additional 500,000 doses of its monkeypox vaccine, Jynneos.

CALIFORNIA

Blaise Group International 
Corporate Headquarters

101 Pacifica, Suite 280
Irvine, CA 92618
Telephone: +1 (949) 502-4070
Fax: +1 (949) 502-4069
[email protected]

NEW YORK

Blaise Group International
New York
New York Rockefeller Center
1 Rockefeller Plz, FL 11
New York, NY 10020
Telephone: +1 (917) 588-3700
Fax: +1 (212) 618-6309
[email protected]

LONDON

 Blaise Group International
London

Berkeley Square House
Berkeley Square 2nd Floor
London W1J6BD United Kingdom
Telephone: +44 20 7887 6197
Fax: +44 20 7887 6001
[email protected]

Contact Us

  • This field is for validation purposes and should be left unchanged.

© 2017 Blaise Group International All rights reserved. Orange County Web Design by LightHouse Graphics